is.\*:(%220343-2521%22)
Results 1 to 25 of 3679
Selection :
Un établissement rural protohistorique et antique au Bois de la Duporterie, à Esvres-sur-Indre (Indre-et-Loire) = A protohistoric and ancient rural settlement at the Bois de la Duporterie, at Esvres-sur-Indre (Indre-et-Loire)TREBUCHET, Emilie.Bulletin de la Société archéologique de Touraine. 2007, Vol 53, pp 77-81, issn 1153-2521, 5 p.Article
Asian producers raise their profiles in the global pharmaceutical value chainVAN ARNUM, Patricia.Pharmaceutical technology (2003). 2006, Vol 30, Num 5, issn 1543-2521, 70-76 [4 p.]Article
Characterization, qualification, and validation of: A bisposable final filling process for parenteral and ophthalmic drugsBELONGIA, Brett M; ALLAY, James A.Pharmaceutical technology (2003). 2006, Vol 30, Num 3, issn 1543-2521, 122-136 [8 p.]Article
Dissolved ozone in pharmaceutical water systenls : How and where to measure dissolved ozoneBLONSHINE, Todd.Pharmaceutical technology (2003). 2006, Vol 30, Num 4, issn 1543-2521, 68-79 [7 p.]Article
Drug delivery trends for parenteral therapeuticsCHAUBAL, Mahesh V; ROSEMAN, Theodore J.Pharmaceutical technology (2003). 2006, Vol 30, Num 10, issn 1543-2521, 110-122 [7 p.]Article
Is satisfactory contractor performance good enough?MILLER, Jim.Pharmaceutical technology (2003). 2006, Vol 30, Num 8, issn 1543-2521, 50-52 [2 p.]Article
Myths, fantasies, and rumors about water system designMANFREDI, Joe.Pharmaceutical technology (2003). 2006, Num CGMP, issn 1543-2521, S28-S38, SUPArticle
Nanoparticle formation: A modular high pressure system to enhance biopharmaceutical properties of poorly soluble drugsSHAH, Umang; VEMAVARAPU, Chandra; ASKINS, Vanessa et al.Pharmaceutical technology (2003). 2006, Vol 30, Num 3, issn 1543-2521, 96-108 [7 p.]Article
Reinventing FDA : A mid-course reportMCCORMICK, Douglas.Pharmaceutical technology (2003). 2006, Vol 30, Num 8, issn 1543-2521, 32-39 [5 p.]Article
Thermal effusivity and power consumption as : PAT tools for monitoring granulation end pointFARISS, Greg; KEINTZ, Roger; OKOYE, Patrick et al.Pharmaceutical technology (2003). 2006, Vol 30, Num 6, issn 1543-2521, 60-72 [7 p.]Article
USP's work plan and new revision approachesCECIL, Todd L; WILLIAMS, Roger L.Pharmaceutical technology (2003). 2006, Vol 30, Num 10, issn 1543-2521, 156-160 [3 p.]Article
Using the bergum method and MS excel to determine : The probability of passing the USP bissolution testCHOLAYUDTH, Pramote.Pharmaceutical technology (2003). 2006, Vol 30, Num 1, pp 88-94, issn 1543-2521, 7 p.Article
Zero-tolerance criteria do not assure product qualityMURPHY, John R; GRIFFITHS, Kristi L.Pharmaceutical technology (2003). 2006, Vol 30, Num 1, pp 52-60, issn 1543-2521, 9 p.Article
Biocatalysis advances in pharmaceutical developmentVAN ARNUM, Patricia.Pharmaceutical technology (2003). 2006, Vol 30, Num 12, pp 50-52, issn 1543-2521, 3 p.Article
An overview of the effect of moisture on compaction and compressionNOKHODCHI, Ali.Pharmaceutical technology (2003). 2005, Vol 29, Num 1, pp 46-66, issn 1543-2521, 11 p.Article
Analytical method equivalency: An acceptable analytical practiceCHAMBERS, Don; KELLY, Gregg; LIMENTANI, Giselle et al.Pharmaceutical technology (2003). 2005, Vol 29, Num 9, pp 64-80, issn 1543-2521, 9 p.Article
Appraisal of the laser diffraction particle-sizing techniqueKIPPAX, Paul.Pharmaceutical technology (2003). 2005, Vol 29, Num 3, pp 88-96, issn 1543-2521, 5 p.Article
Automating HPLC and GC analytical method validationLUKULAY, Patrick; VERSEPUT, Richard.Pharmaceutical technology (2003). 2005, Vol 29, Num 5, pp 66-71, issn 1543-2521, 5 p.Article
Comparative evaluation of three active air samplers : for the monitoring of airborne microorganismsDER, Evelyn F; STABLEIN, Joe P; COLEMAN, Daniel A et al.Pharmaceutical technology (2003). 2005, Vol 29, Num 4, pp 110-116, issn 1543-2521, 4 p.Article
Implications of photostability on the manufacturing, packaging, storage, and testing of formulated pharmaceutical productsTEMPLETON, Allen C; HUI XU; PLACEK, Jiri et al.Pharmaceutical technology (2003). 2005, Vol 29, Num 3, pp 68-84, issn 1543-2521, 9 p.Article
Importance of background microbial levels in the manufacture and testing of sterile productsAGALLOCO, James.Pharmaceutical technology (2003). 2005, Vol 29, Num 4, pp 74-80, issn 1543-2521, 4 p.Article
Management controls for GMP complianceCHESNEY, David L.Pharmaceutical technology (2003). 2005, Vol 29, Num 4, pp 64-72, issn 1543-2521, 4 p.Article
Outsourcing beyond the comfort zonePADDISON, Chris; WHITE, Chris; CRUICKSHANK, Carol et al.Pharmaceutical technology (2003). 2005, pp 24-34, issn 1543-2521, 6 p., SUPArticle
Price mattersMILLER, Jim.Pharmaceutical technology (2003). 2005, Vol 29, Num 5, pp 84-86, issn 1543-2521, 2 p.Article
Reducing time to market with : A science-based product management strategyBYRN, Stephen; MORRIS, Kenneth; COMELLA, Shawn et al.Pharmaceutical technology (2003). 2005, pp 46-56, issn 1543-2521, 6 p., SUPArticle